ELDN R&D Expense Growth
Eledon Pharmaceuticals Inc · R&D Expense Growth
ELDN R&D Expense Growth
Latest reported27.52%period ending
ELDN FY R&D Growth (YoY) (0.00% → 27.52%)
Latest values, visible window
High-resolution chart · PNG
ELDN r&d expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| 27.5248% | |
| 71.4305% | |
| 11.935% | |
| 14.0931% | |
| 287.131% | |
| -24.5694% | |
| 19.2313% | |
| 237.1414% | |
| -91.9198% | |
| -23.3286% | |
| 123.9007% | |
| 19.4738% | |
| 65.5495% | |
| 0% |